Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Nov 23, 2010
IR Global Rankings (IRGR) is pleased to announce that it will collaborate with Institutional Investor magazine on a series of Investor Relations events...
-
Nov 10, 2010
Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the Credit Suisse Annual...
-
Nov 9, 2010
JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 11/09/10 -- www.wallstreetequityresearch.com brings investors market knowledge on the aspects moving the drug related products stocks, and offers...
-
Nov 2, 2010
Fiscal first quarter revenue from continuing operations increased $113 million, or 21 percent, to a record $641 million Fiscal first quarter...
-
Oct 27, 2010
Perrigo Company (Nasdaq: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.07 per share, payable on...
-
Oct 19, 2010
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it will release financial results for its first quarter fiscal 2011 on Tuesday, November...
-
Sep 24, 2010
Perrigo Company (Nasdaq: PRGO; TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug...
-
Sep 8, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced it received FDA approval from the U.S. Food and Drug Administration to manufacture and market Imiquimod Cream, 5%. Perrigo will vertically...
-
Sep 2, 2010
JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 09/02/10 -- www.wallstreetequityresearch.com gives shareholders valuable insight on drug related products stocks Perrigo Co. (NASDAQ: PRGO) and NBTY...
-
Aug 25, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced it received FDA clearance on August 23, 2010 to manufacture infant formula liquid concentrate and ready-to-use products through its partner...